Emerging-Market Specialist Nycomed Acquires Majority Stake In China's Guangdong Techpool Bio-Pharma

This article was originally published in The Pink Sheet Daily

01 Nov 2010
News

John Davis john.davis@informa.com

Executive Summary

Swiss Nycomed has acquired a majority stake in Guangdong Techpool Bio-Pharma for €210 million to expand its Chinese operations.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Industries
BioPharmaceutical
Regions
Asia Pacific

China

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical China

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS071417

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS071417

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Emerging-Market Specialist Nycomed Acquires Majority Stake In China's Guangdong Techpool Bio-Pharma

News

Executive Summary

Related Content

Nycomed To Beef Up Sales In China Through Buyout; Bets On India For Global API Supplies

Nycomed To Beef Up Sales In China Through Buyout; Bets On India For Global API Supplies

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert